Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions. [PDF]
Ismail A, Desai A, Simon GR, Boumber Y.
europepmc +1 more source
A high-throughput fluorescent DNA cleavage assay for discovering bacterial DNA gyrase poisons. [PDF]
Dias M +9 more
europepmc +1 more source
Novel <i>N</i>-4-(5-Amino-7-substituted-triazolotriazinepiperazin-1-yl) Norfloxacin Analogues Exhibit Potent and Selective Anticancer Activity via Topoisomerase Inhibition, Cell-Cycle Arrest, and Apoptosis in A 431 Skin Carcinoma Cells. [PDF]
El-Saghier AM +4 more
europepmc +1 more source
Evolution and recent advances in antibody-drug conjugate therapy for lung cancer: a comprehensive systematic review based on the Trialtrove database (inception to July 1, 2025). [PDF]
Chen Y, Zhang Y, Tian C, Li Z, Guo G.
europepmc +1 more source
Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activity. [PDF]
Eldehna WM +11 more
europepmc +1 more source
Cellular strategies for repairing trapped protein-DNA complexes. [PDF]
Sideridou M +3 more
europepmc +1 more source
In silico evaluation of garlic-derived organosulfur compounds as multi-target inhibitors of breast cancer biomarkers. [PDF]
Siame C, Ofori B, Paemka L, Danquah KO.
europepmc +1 more source
Topoisomerases as Targets for Novel Drug Discovery. [PDF]
Perdih A.
europepmc +1 more source
Amonafide Targeting NTSR1-PI3K/AKT/mTOR Signaling Attenuates Vascular Remodeling in Pulmonary Arterial Hypertension. [PDF]
Zhu YJ +13 more
europepmc +1 more source
Total body irradiation and smoking interact to increase lung cancer risk after blood or marrow transplantation. [PDF]
Balas N +11 more
europepmc +1 more source

